. Author manuscript; available in PMC: 2024 May 1.

Published in final edited form as: J Magn Reson Imaging. 2022 Sep 27;57(5):1552–1564. doi: 10.1002/jmri.28439

Table 2.

Cognitive Performance at baseline and after one-month treatment (mean ± standard error) in adaptive group.

Cognitive z-scores	TL1 (n = 58)			TL2 (n = 58)
Cognitive z-scores	SN (n = 28)	PWH (n = 30)	p	SN (n = 28)	PWH (n = 30)	p
Fluency	−0.10±0.14	−0.13±0.13	0.904	0.00±0.12	−0.12±0.13	0.500
Executive function	−0.15±0.15	−0.31±0.12	0.385	−0.06±0.15	−0.29±0.15	0.283
Speed	−0.10±0.13	−0.30±0.10	0.210	−0.13±0.14	−0.32±0.13	0.334
Attention	0.05±0.13	−0.42±0.14	0.016	0.20±0.16	−0.21±0.15	0.069
Learning	0.06±0.17	−0.21±0.12	0.192	0.21±0.17	−0.14±0.13	0.112
Memory	0.43±0.13	0.09±0.14	0.075	−0.03±0.15	−0.08±0.15	0.814

SN: seronegative controls; PWH: people with human immunodeficiency virus; TL1: baseline; TL2: one-month after treatment; n: number of participants; p: from two-sample t-test between PWH and SN.